APA (7th ed.) Citation

CF, W., SC, K., J, G., L, J., J, S., A, S., & K, S. G. (2026). Patient Survival and Its Relation to Tumor Absorbed Dose in [177Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 67(10), 1586. https://doi.org/10.2967/jnumed.125.271439

Chicago Style (17th ed.) Citation

CF, Warfvinge, Kapidzic SC, Gustafsson J, Jessen L, Svensson J, Sundlöv A, and Sjögreen Gleisner K. "Patient Survival and Its Relation to Tumor Absorbed Dose in [177Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 67, no. 10 (2026): 1586. https://doi.org/10.2967/jnumed.125.271439.

MLA (9th ed.) Citation

CF, Warfvinge, et al. "Patient Survival and Its Relation to Tumor Absorbed Dose in [177Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 67, no. 10, 2026, p. 1586, https://doi.org/10.2967/jnumed.125.271439.